1,3-Bis(4-bromophenyl)thiourea

Catalog No.: 
ACLPQZ717
CAS No.: 
2059-75-8
Molecular Formula: 
C13H10Br2N2S
Molecular Weight: 
386.11
1,3-Bis(4-bromophenyl)thiourea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$83.00In stockInquiry
100mg95%$138.00In stockInquiry
250mg95%$276.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Bis(4-bromophenyl)thiourea
IUPAC Name1,3-bis(4-bromophenyl)thiourea
MDL No.MFCD00158766
Molecular FormulaC13H10Br2N2S
Molecular Weight386.11
SMILESS=C(NC1=CC=C(Br)C=C1)NC2=CC=C(Br)C=C2
InChI KeyRQVXFYAPGIMASB-UHFFFAOYSA-N
SynonymThiourea,N,N'-bis(4-bromophenyl)-;N,N'-bis(p-bromophenyl)thiourea;1,3-BIS(4-BROMOPHENYL)-2-THIOUREA;1,3-bis(4-bromophenyl)thiourea;N,N'-bis(4-bromophenyl)-Thiourea
CAS No.2059-75-8

Safety Data

Pictogram
CorrosiveHarmful or irritantEnvironmental hazard
Signal Word
Danger
Hazard Statement(s)
H302-H315-H318-H335-H410
Precautionary Statement(s)
P261-P273-P280-P305+P351+P338-P501

Synthetic Route by SureRoute

1. ACLPQZ717 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXDSQ392 route compound structure diagram
    ACXDSQ3921985-12-2In Stock
  4. Then
  5. ACLPQZ717 route product structure diagram
    ACLPQZ7172059-75-8In Stock
Inquiry

2. ACLPQZ717 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLPQZ717 route product structure diagram
    ACLPQZ7172059-75-8In Stock
Inquiry

3. ACLPQZ717 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLPQZ717 route product structure diagram
    ACLPQZ7172059-75-8In Stock
Inquiry

Comments (0)